A new Covid Response Report (CRR), produced by Oxford Business Group (OBG) in partnership with the digital health platform Altibbi, explores the rapid development and uptake of medical and health technology across four MENA markets in 2020.
By Component, By Enterprise Size (Large Enterprise, Small & Medium Enterprises (SMEs)), By End-use (Restaurants, Retail, Healthcare, Entertainment, Others (Government, Transportation, etc.)) and Regional Forecast, 2020-2027
The global energy management systems market size valued at USD 18,269.6 Million in 2018 and is projected to reach USD 48,901.1 Million by the end of 2026, exhibiting a CAGR of 13.7% during the forecast period (2019 - 2026).
The global development and operations (DevOps) market size stood at USD 3,709.1 million in 2018 and is projected to reach USD 14,969.6 million by 2026, exhibiting a CAGR of 19.1% during the forecast period.
The approval of KYMRIAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity.
Rise in prevalence of chronic diseases and the corresponding need to medicate frequently, have led to an increase in demand for safe, self-administrable dosing options. Autoinjectors are considered among the leading product classes in this category
In order to reduce risk of device recalls and expedite time to market, medical device developers rely on contract service providers for regulatory submissions and navigating various challenging aspects of the product review and approval process
The report evaluates the factors that will play the most influential role in the growth of the market. Fraudulent activity can be understood as any kind of deception that is criminal in nature and is performed for financial or personal gain.